Feed/Investors/Jacques Boitreaud

Jacques Boitreaud

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Individual investorSince 2026-11-12

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$33.4M

across 1 round

LATEST ROUND

Series A · $33.4M · 2026-11-12

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Orakl Oncology A French TechBio company using AI and real patient biology to predict how cancer drugs will perform in clinical trials	Series A Verified against 4 of 5 sources	$33.4M	2026-11-12	[ PART ]